- Home
- ZCMD vs PMN Comparison
ZCMD vs PMN Comparison
Compare ZCMD & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- PMN
- Stock Information
- Founded
- ZCMD 2012
- PMN 2004
- Country
- ZCMD China
- PMN Canada
- Employees
- ZCMD N/A
- PMN N/A
- Industry
- ZCMD Other Consumer Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- ZCMD Real Estate
- PMN Health Care
- Exchange
- ZCMD Nasdaq
- PMN Nasdaq
- Market Cap
- ZCMD 29.0M
- PMN 17.0M
- IPO Year
- ZCMD 2020
- PMN N/A
- Fundamental
- Price
- ZCMD $1.22
- PMN $0.49
- Analyst Decision
- ZCMD
- PMN Strong Buy
- Analyst Count
- ZCMD 0
- PMN 2
- Target Price
- ZCMD N/A
- PMN $4.50
- AVG Volume (30 Days)
- ZCMD 648.0K
- PMN 39.5K
- Earning Date
- ZCMD 01-01-0001
- PMN 08-07-2025
- Dividend Yield
- ZCMD N/A
- PMN N/A
- EPS Growth
- ZCMD N/A
- PMN N/A
- EPS
- ZCMD N/A
- PMN N/A
- Revenue
- ZCMD $15,864,773.00
- PMN N/A
- Revenue This Year
- ZCMD N/A
- PMN N/A
- Revenue Next Year
- ZCMD N/A
- PMN N/A
- P/E Ratio
- ZCMD N/A
- PMN N/A
- Revenue Growth
- ZCMD N/A
- PMN N/A
- 52 Week Low
- ZCMD $0.95
- PMN $0.47
- 52 Week High
- ZCMD $2.97
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- ZCMD 53.68
- PMN 45.60
- Support Level
- ZCMD $1.06
- PMN $0.48
- Resistance Level
- ZCMD $1.28
- PMN $0.53
- Average True Range (ATR)
- ZCMD 0.17
- PMN 0.02
- MACD
- ZCMD 0.00
- PMN 0.00
- Stochastic Oscillator
- ZCMD 54.02
- PMN 26.86
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.